Abstract:Transcription activator-like effectors (TALEs), first identified in Xanthomonas bacteria, are naturally occurring or artificially designed proteins that modulate gene transcription. These proteins recognize and bind DNA sequences based on a variable numbers of tandem repeats. Each repeat is comprised of a set of ∼ 34 conserved amino acids; within this conserved domain, there are usually two amino acids that distinguish one TALE from another. Interestingly, TALEs have revealed a simple cipher for the one-to-one recognition of proteins for DNA bases. Synthetic TALEs have been used to successfully target genes in a variety of species, including humans. Depending on the type of functional domain that is fused to the TALE of interest, these proteins can have diverse biological effects. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Targeted genome editing, in theory, is capable of modifying any endogenous gene sequence of interest; this can be performed in cells or organisms, and may be applied to clinical gene-based therapies in the future. With current technologies, highly accurate, specific, and reliable gene editing cannot be achieved. Thus, recognition and binding mechanisms governing TALE biology are currently hot research areas. In this review, we summarize the major advances in TALE technology over the past several years with a focus on the interaction between TALEs and DNA, TALE design and construction, potential applications for this technology, and unique characteristics that make TALEs superior to zinc finger endonucleases.

TALE Nickase Mediates High Efficient Targeted Transgene Integration at the Human Multi-Copy Ribosomal DNA Locus.

Targeted Gene Addition to A Predetermined Site in the Human Genome Using A Zfn-Based Nicking Enzyme

High-Efficiency And Heritable Gene Targeting In Mouse By Transcription Activator-Like Effector Nucleases

De Novo-Engineered Transcription Activator-Like Effector (TALE) Hybrid Nuclease with Novel DNA Binding Specificity Creates Double-Strand Breaks.

Molecular “Scissors” ——TALENs Mediated Site-specific Gene Modification Technology

Creating A Monomeric Endonuclease Tale-I-Scei with High Specificity and Low Genotoxicity in Human Cells

Efficient Production of a Gene Mutant Cell Line Through Integrating TALENs and High-Throughput Cell Cloning.

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

A Highly Efficient Site-Specific Integration Strategy Using Combination of Homologous Recombination and the ΦC31 Integrase.

[TALE Nuclease Engineering and Targeted Genome Modification].

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

TALE: a tale of genome editing.

Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification

Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells.

All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons

Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids

A single-chain TALEN architecture for genome engineering.

Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases

Inheritable and Precise Large Genomic Deletions of Non-Coding RNA Genes in Zebrafish Using TALENs.